← Open Payments lookup

LUCILLE VON ROEMER: Open Payments

NPI 1700573128 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,389 in 58 payments from 14 companies in 2025. Trend: 2023 $310 · 2024 $1,134 · 2025 $1,389

Food & beverage: $1,389
CompanyPaymentsAmount
Madrigal Pharmaceuticals11$417
ABBVIE INC.23$382
Gilead Sciences, Inc.4$175
VIVUS LLC3$65
Lilly USA, LLC3$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$56
Novo Nordisk Inc2$43
Aimmune Therapeutics, Inc.2$42
Boehringer Ingelheim Pharmaceuticals, Inc.1$34
Phathom Pharmaceuticals, Inc.2$33

Products named: REZDIFFRA, RINVOQ, SKYRIZI, CREON, OMVOH, XIFAXAN, PANCREAZE, Wegovy.

Industry payments across GA — which companies pay providers there.